LADENBURG THALMANN FINANCIAL SERVICES INC. - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 165 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2015. The put-call ratio across all filers is 4.61 and the average weighting 0.1%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2018$1,000
-85.7%
7,400
-54.9%
0.00%
Q3 2018$7,000
+600.0%
16,400
+4000.0%
0.00%
Q2 2018$1,0000.0%4000.0%0.00%
Q1 2018$1,0000.0%4000.0%0.00%
Q4 2017$1,0000.0%4000.0%0.00%
Q3 2017$1,0000.0%400
-2.4%
0.00%
Q2 2017$1,000
-80.0%
410
-67.8%
0.00%
Q1 2017$5,000
+150.0%
1,273
+89.2%
0.00%
Q4 2016$2,000
-50.0%
673
-35.8%
0.00%
Q3 2016$4,0000.0%1,048
+23.6%
0.00%
Q2 2016$4,000
-20.0%
848
-35.7%
0.00%
Q1 2016$5,000
-79.2%
1,318
-15.7%
0.00%
Q4 2015$24,000
+20.0%
1,563
-16.1%
0.00%
Q3 2015$20,000
-39.4%
1,863
+44.6%
0.00%
-100.0%
Q2 2015$33,000
+37.5%
1,288
+45.0%
0.00%
Q1 2015$24,0000.0%888
-32.5%
0.00%
-100.0%
Q4 2014$24,000
+2300.0%
1,315
+1043.5%
0.00%
Q3 2014$1,000
-98.0%
115
-96.3%
0.00%
-100.0%
Q2 2014$50,000
+35.1%
3,070
+46.2%
0.00%0.0%
Q1 2014$37,000
-19.6%
2,100
+10.5%
0.00%0.0%
Q4 2013$46,000
-89.6%
1,900
-84.7%
0.00%
-93.3%
Q3 2013$441,000
+141.0%
12,450
+6.0%
0.02%
+114.3%
Q2 2013$183,00011,7500.01%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q3 2015
NameSharesValueWeighting ↓
TSP Capital Management Group, LLC 876,020$31,037,00013.97%
Private Capital Advisors, Inc. 173,191$6,136,0002.23%
ARDSLEY ADVISORY PARTNERS LP 265,000$9,389,0001.92%
SECTORAL ASSET MANAGEMENT INC 944,522$33,464,0001.61%
EMERALD MUTUAL FUND ADVISERS TRUST 446,824$15,830,0001.09%
KOPP INVESTMENT ADVISORS LLC 72,755$2,578,0000.95%
EMERALD ADVISERS, LLC 455,619$16,143,0000.91%
Cupps Capital Management, LLC 254,655$9,022,0000.58%
HealthCor Management, L.P. 300,000$10,629,0000.57%
EAM Investors, LLC 79,486$2,816,0000.56%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders